Search research articles
Contact Us
Filters
Showing results (221-230 of 235) with videos related to
Page
of 24
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 20, 1998
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1)
S von Mensdorff-Pouilly, M M Gourevitch, P Kenemans, et al.
Cancer Letters
|
June 3, 1997
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes
C J Vennegoor, H W Nijman, J W Drijfhout, et al.
Climacteric : the Journal of the International Menopause Society
|
December 5, 2009
Therapeutic options for postmenopausal female sexual dysfunction
F Al-Azzawi, J Bitzer, U Brandenburg, et al.
Journal of Clinical Pathology
|
November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations
R P Zweemer, P A Shaw, R M Verheijen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 29, 2007
Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation
B B J Hermsen, R H M Verheijen, F H Menko, et al.
The Journal of Pathology
|
December 18, 2001
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
J M Piek, P J van Diest, R P Zweemer, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 13, 2001
Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma
R P Zweemer, A Ryan, A M Snijders, et al.
Molecular Pathology : MP
|
October 2, 2002
Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer
A P M Jongsma, J M J Piek, R P Zweemer, et al.
International Journal of Cancer
|
May 8, 2000
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides
S von Mensdorff-Pouilly, E Petrakou, P Kenemans, et al.
Cancer Research
|
November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose
A C van Hof, C F Molthoff, Q Davies, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 235) with videos related to
Sort By:
Page
of 24
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 20, 1998
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1)
S von Mensdorff-Pouilly, M M Gourevitch, P Kenemans, et al.
Cancer Letters
|
June 3, 1997
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes
C J Vennegoor, H W Nijman, J W Drijfhout, et al.
Climacteric : the Journal of the International Menopause Society
|
December 5, 2009
Therapeutic options for postmenopausal female sexual dysfunction
F Al-Azzawi, J Bitzer, U Brandenburg, et al.
Journal of Clinical Pathology
|
November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations
R P Zweemer, P A Shaw, R M Verheijen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 29, 2007
Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation
B B J Hermsen, R H M Verheijen, F H Menko, et al.
The Journal of Pathology
|
December 18, 2001
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
J M Piek, P J van Diest, R P Zweemer, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 13, 2001
Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma
R P Zweemer, A Ryan, A M Snijders, et al.
Molecular Pathology : MP
|
October 2, 2002
Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer
A P M Jongsma, J M J Piek, R P Zweemer, et al.
International Journal of Cancer
|
May 8, 2000
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides
S von Mensdorff-Pouilly, E Petrakou, P Kenemans, et al.
Cancer Research
|
November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose
A C van Hof, C F Molthoff, Q Davies, et al.
Page
of 24